- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05492526
The Use of Contextualised Body Data in Cardiac Rehabilitation (CR) (KiCS1)
Using Body Data for the Purpose of Contextualised Feedback to Enable Established Physical Activity Guidelines to be Delivered in a Free- Living Environment as Part of a Comprehensive Cardiac Rehabilitation Programme.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Cardiac rehabilitation (CR) after a heart attack has shown to be more effective than any other medication given after such an event. It is a recommended therapy by NICE. However, only 44% of eligible patients attend rehabilitation and only half of these complete the course. Novel ways to increase uptake and compliance are needed.
In this study, calorie burn and physical activity data will be collected using a validated, CE marked physical activity monitor, herein referred to as Ki monitor. Data can be uploaded to an online behaviour change platform that incorporates personalised feedback in the context of their bespoke requirements for CR to empower people to self-care at home using their personal everyday physical activity. This can be closely monitored and support can be given on the contextualised feedback by healthcare professionals. A small pilot study has been carried out to establish wearability of a physical activity monitor in a CR cohort, which has demonstrated a high level of acceptability.
We now wish to extend this pilot to a randomised study designed to test the effectiveness of using contextualised body data to influence physical activity in a free-living environment amongst patients undergoing CR, based on the current ACPICR standards for Daily Activity and At-home Training. All patients referred for CR will be invited to take part. These will be randomised to the usual care (UC) group or the contextualised data feedback (CDF) group. Both groups will wear the Ki monitor for eight weeks. The UC group will receive usual care, the CDF group will receive usual care with the addition of contextualised feedback on their activities based on the physical activity data.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Liverpool, United Kingdom, L78xp
- Liverpool University Hospital NHS Foundation Trust
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
All patients referred to the cardiac rehab programme will be invited to take part in the study.
Exclusion Criteria:
- Individuals using a pacemaker or other internal medical device.
- Unable to access a computer or tablet with internet access to view the online platform.
- Unable to access a smartphone or tablet with bluetooth connectivity and internet access to upload data from the activity monitor.
- Unwillingness to take part.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Usual Cardiac Rehabilitation
Patients receive usual care and wear Ki monitor - doesn't receive any feedback during the cardiac rehabilitation period.
|
Physical activity Monitor - No feedback
|
|
Experimental: Intervention Arm - Usual Cardiac Rehabilitation plus contextualised Data feedback
Patient receives usual care and also wears Ki monitor and receives contextualised data feedback
|
Physical activity monitor and feedback
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Achieving the ACPICR standards for physical activity in a free-living environment objectively measured using the Ki monitor
Time Frame: 6 - 8 weeks
|
Objective measurement using Ki monitor.
|
6 - 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Exercise test result.
Time Frame: 6-8 weeks
|
Incremental shuttle walk test or 6 minute walking test, as appropriate
|
6-8 weeks
|
|
Total calories burned
Time Frame: 6-8 weeks
|
Objectively measured using the Ki monitor
|
6-8 weeks
|
|
Completion of cardiac rehabilitation programme
Time Frame: 6-8 weeks
|
Number of participants completed full cardiac rehabilitation programme.
|
6-8 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality of life measured using the Dartmouth Coop
Time Frame: 6-8 weeks
|
Participants completed a questionnaire at the start and end of the cardiac rehabilitation program.
|
6-8 weeks
|
|
Anxiety and depression score measured using Hospital Anxiety and depression scale (HADS)
Time Frame: 6-8 weeks
|
Participants completed a questionnaire at the start and end of the cardiac rehabilitation program.
|
6-8 weeks
|
|
Body mass index measured using height and weight and combined to report in kg/m2
Time Frame: 6-8 weeks
|
Measured at the beginning and end of Cardiac rehabilitation programme
|
6-8 weeks
|
|
Blood pressure measured and reported in mmHg
Time Frame: 6- 8 weeks
|
Measured before and after exercise tests at the beginning and end of the cardiac rehabilitation programme
|
6- 8 weeks
|
|
Blood Glucose measured and reported in mmol/L
Time Frame: 6-8 weeks
|
Measured at the beginning and end of Cardiac rehabilitation programme where appropriate
|
6-8 weeks
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Micheal Fisher, Liverpool University Hospitals NHS Trust
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 4807
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiac Rehabilitation
-
Pakistan Institute of Medical SciencesNot yet recruiting
-
Mayo ClinicRecruitingCardiac RehabilitationUnited States
-
I.R.C.C.S. Fondazione Santa LuciaUniversity of Roma La SapienzaCompleted
-
Defactum, Central Denmark RegionCompleted
-
Ivy susanne Modrau, MDAalborg University HospitalEnrolling by invitationCardiac RehabilitationDenmark
-
University of Central LancashireUniversity of Hull; Sheffield Hallam University; Leeds Beckett UniversityWithdrawnCardiac RehabilitationUnited Kingdom
-
University of North Carolina, Chapel HillNational Institutes of Health (NIH)CompletedCardiac RehabilitationUnited States
-
Shanghai Zhongshan HospitalNot yet recruiting
-
University of ValenciaActive, not recruitingCardiac RehabilitationSpain
-
Texas A&M UniversityAscension HealthActive, not recruiting
Clinical Trials on Ki Monitor without feedback
-
University of Mogi das CruzesCompletedBalancing InterferenceBrazil
-
Cedars-Sinai Medical CenterUnknownSurgeryUnited States
-
University Hospital, CaenUnknown
-
Sheffield Hallam UniversitySheffield Children's NHS Foundation TrustCompleted
-
Khon Kaen UniversityCompletedSpinal Cord InjuriesThailand
-
Mayo ClinicJR Albert FoundationCompleted
-
University of ChicagoLaerdal MedicalTerminated
-
Vimonwan HiengkaewUnknownStroke | Movement, Abnormal
-
McGill UniversityCompleted
-
Università degli Studi dell'InsubriaCompletedFemoral Fractures | Knee Arthroplasty | Ankle Fractures | Hip Arthroplasty | Pelvic Fractures | Hip Fractures (ICD-10 72.01-72.2)Italy